Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Watchlist
Price: 15.66 USD -3.57% Market Closed
Market Cap: 1.3B USD

Wall Street
Price Targets

SNDX Price Targets Summary
Syndax Pharmaceuticals Inc

Wall Street analysts forecast SNDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNDX is 38.11 USD with a low forecast of 19.19 USD and a high forecast of 58.8 USD.

Lowest
Price Target
19.19 USD
23% Upside
Average
Price Target
38.11 USD
143% Upside
Highest
Price Target
58.8 USD
275% Upside
Syndax Pharmaceuticals Inc Competitors:
Price Targets
600161
Beijing Tiantan Biological Products Corp Ltd
24% Upside
REGN
Regeneron Pharmaceuticals Inc
30% Upside
HPHA
Heidelberg Pharma AG
217% Upside
AMRN
Amarin Corporation PLC
27% Downside
IDYA
IDEAYA Biosciences Inc
84% Upside
IMMU
Mendus AB (publ)
268% Upside
AMGN
Amgen Inc
11% Upside
096530
Seegene Inc
67% Upside

Revenue
Forecast

Revenue Estimate
Syndax Pharmaceuticals Inc

The compound annual growth rate of Syndax Pharmaceuticals Inc's revenue for the next 3 years is 163%.

N/A
Past Growth
163%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Syndax Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNDX's stock price target?
Price Target
38.11 USD

According to Wall Street analysts, the average 1-year price target for SNDX is 38.11 USD with a low forecast of 19.19 USD and a high forecast of 58.8 USD.

What is Syndax Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
163%

The compound annual growth rate of Syndax Pharmaceuticals Inc's revenue for the next 3 years is 163%.

Back to Top